BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 38146560)

  • 1. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
    Agnese ER; Tariche N; Sharma A; Gulati R
    Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life.
    Nguyen TV; Damiani G; Orenstein LAV; Hamzavi I; Jemec GB
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):50-61. PubMed ID: 32460374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenitis suppurativa: Epidemiology, clinical presentation, and pathogenesis.
    Goldburg SR; Strober BE; Payette MJ
    J Am Acad Dermatol; 2020 May; 82(5):1045-1058. PubMed ID: 31604104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
    Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
    Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis Suppurativa at an Uncommon Site: A Review of Its Clinical Features, Diagnostic Difficulties, and Management.
    Harvey LM; Fortson JK
    Cureus; 2021 Oct; 13(10):e18704. PubMed ID: 34790460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of hidradenitis suppurativa/acne inversa].
    Nikolakis G; Kokolakis G; Kaleta K; Wolk K; Hunger R; Sabat R; Zouboulis CC
    Hautarzt; 2021 Aug; 72(8):658-665. PubMed ID: 34228138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives on the treatment of hidradenitis suppurativa.
    Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
    Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of hidradenitis suppurativa.
    Yuan JT; Naik HB
    Semin Cutan Med Surg; 2017 Jun; 36(2):79-85. PubMed ID: 28538749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidradenitis suppurativa and associated diseases.
    Pescitelli L; Ricceri F; Prignano F
    G Ital Dermatol Venereol; 2018 Jun; 153(3 Suppl 2):8-17. PubMed ID: 30468375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis Suppurativa: Consequences of Microbiome Dysbiosis on Immune Dysregulation and Disease Severity.
    Chung MG; Preda-Naumescu A; Yusuf N
    Indian J Dermatol; 2022; 67(6):699-704. PubMed ID: 36998859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into hidradenitis suppurativa.
    van Straalen KR; Prens EP; Gudjonsson JE
    J Allergy Clin Immunol; 2022 Apr; 149(4):1150-1161. PubMed ID: 35189127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Update on Current Clinical Management and Emerging Treatments in Hidradenitis Suppurativa.
    Miller A; Shahzeidi P; Bernhardt M
    Skin Therapy Lett; 2024 Mar; 29(2):1-6. PubMed ID: 38574201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidities of hidradenitis suppurativa: A review of the literature.
    Cartron A; Driscoll MS
    Int J Womens Dermatol; 2019 Dec; 5(5):330-334. PubMed ID: 31909152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations.
    Preda-Naumescu A; Ahmed HN; Mayo TT; Yusuf N
    Int J Dermatol; 2021 Nov; 60(11):e449-e458. PubMed ID: 33890304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
    Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
    Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
    Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of macrophages in the pathogenesis of hidradenitis suppurativa.
    Shah A; Alhusayen R; Amini-Nik S
    Inflamm Res; 2017 Nov; 66(11):931-945. PubMed ID: 28656364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression As a Potential Contributing Factor in Hidradenitis Suppurativa and Associated Racial Gaps.
    Okwundu N; McMichael AJ
    Cutis; 2024 Mar; 113(3):137-140. PubMed ID: 38648594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
    Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
    Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.